Is mefenamic acid (Nonsteroidal Anti-Inflammatory Drug (NSAID)) effective for toothache pain?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 10, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Mefenamic Acid for Toothache Pain

Mefenamic acid 500 mg is an effective NSAID option for acute toothache pain, with proven efficacy in dental pain management, though it offers no clear advantage over other NSAIDs like ibuprofen and carries a higher risk of gastrointestinal toxicity. 1, 2

Efficacy for Dental Pain

  • Mefenamic acid 500 mg provides at least 50% pain relief in acute postoperative pain with an NNT of 4.0 (95% CI: 2.7-7.1) over 6 hours, based on data that included dental extraction pain. 3

  • The drug demonstrates analgesic efficacy through COX-1 and COX-2 inhibition, reducing prostaglandin synthesis that sensitizes pain nerves. 4

  • Peak plasma levels of 10-20 mcg/mL are reached within 2-4 hours after oral administration, providing relatively rapid pain relief. 4

Dosing Recommendations

  • Standard dosing is 500 mg capsules, with a maximum daily dose of 2000 mg (4 × 500 mg). 1

  • The elimination half-life is approximately 2 hours, requiring dosing every 6-8 hours for sustained pain control. 4

  • Mefenamic acid is rapidly absorbed after oral administration, with steady-state concentrations achieved quickly due to the short half-life. 4

Safety Concerns and Comparative Profile

  • Mefenamic acid has a less favorable safety profile compared to other NSAIDs, with higher rates of upper gastrointestinal lesions and renal insufficiency, particularly with prolonged use. 2

  • Systemic toxicity can occur at relatively low doses above the maximum daily dose compared to other NSAIDs. 2

  • Like all NSAIDs, use with caution in patients at high risk for renal, GI, or cardiac toxicities, particularly those over 60 years, with peptic ulcer history, or on anticoagulants. 1

  • Rare but serious central nervous system toxicity has been reported, including altered mental status and metabolic acidosis, even with therapeutic dosing. 5

Clinical Positioning

  • There is no evidence that mefenamic acid is more effective than other NSAIDs for dental pain, and current literature does not support preferring it over alternatives like ibuprofen or naproxen. 2

  • For toothache pain specifically, ibuprofen 400-600 mg every 6 hours (maximum 2400-3200 mg/day) remains a safer first-line option with comparable efficacy. 1

  • Consider mefenamic acid only if the patient has previously tolerated it well or has contraindications to other NSAIDs. 1

Monitoring Requirements

  • Baseline assessment of renal function (BUN, creatinine), liver function, and blood pressure is prudent, especially for use beyond 3-5 days. 1

  • Discontinue if BUN or creatinine doubles, liver function tests exceed 3 times upper limit of normal, or gastrointestinal bleeding occurs. 1

Key Contraindications

  • Active peptic ulcer disease, severe heart failure, liver failure, or history of GI bleeding are absolute contraindications. 1

  • Avoid in patients with significant renal impairment, as mefenamic acid is primarily renally excreted (52% as glucuronide metabolites). 4

  • Use extreme caution with concomitant anticoagulants, as bleeding risk increases 3-6 fold. 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

[Mefenamic acid and other non-steroidal anti-inflammatory agents in dental practice. A review of the literature].

Schweizer Monatsschrift fur Zahnmedizin = Revue mensuelle suisse d'odonto-stomatologie = Rivista mensile svizzera di odontologia e stomatologia, 2007

Research

Single dose oral mefenamic acid for acute postoperative pain in adults.

The Cochrane database of systematic reviews, 2011

Research

Central nervous system toxicity due to mefenamic acid.

The American journal of emergency medicine, 2019

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.